Why the study?
Does continuous intravenous infusion chemotherapy via a portable device provide similar plasma levels and safety compared to standard inpatient delivery in patients with locally advanced head and neck cancer?
Does continuous intravenous infusion chemotherapy via a portable device provide similar plasma levels and safety compared to standard inpatient delivery in patients with locally advanced head and neck cancer?
Outpatient continuous intravenous infusion chemotherapy via a portable device is a reliable, cost-effective, and well-accepted alternative to inpatient hospitalization for patients with head and neck cancer.
No takes yet. Share an insight, caveat, or question.
Portable infusors yield equivalent 5-FU exposure to standard pumps; supports outpatient delivery as a reliable alternative in head and neck cancer.
Vokes et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: